A study to investigate effect of Bortezomib with or without Thalidomide on platelet aggregation in patients with relapsed or refractory multiple myeloma.
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2015
At a glance
- Drugs Bortezomib (Primary) ; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 29 Nov 2015 New trial record